| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Wednesday’s Close |
|---|---|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries Limited | $23.43 | $23.86B | N/A |
Endo's (ENDP) BLA for Cellulite Treatment Accepted by FDA
http://www.zacks.com/stock/news/631469/endos-endp-bla-for-cellulite-treatment-accepted-by-fda?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-631469
Nov 21, 2019 - The FDA accepts Endo's (ENDP) BLA for CCH for the treatment of cellulite in the buttocks.
0
Teva Is Due For A Substantial Re-Rating
https://seekingalpha.com/article/4308148-teva-due-substantial-re-rating?source=feed_tag_israel
Nov 20, 2019 - Thanks to its debt offering, a heavily dilutive equity issuance has become very unlikely.The upsized offering also highlights that debt markets are not seeing a large bankruptcy risk.The only remainin
0
Teva Is Due For A Substantial Re-Rating
https://seekingalpha.com/article/4308148-teva-is-due-for-substantial-re-rating?source=feed_tag_israel
Nov 20, 2019 -
0
Teva, Bausch Could Be Next to File for Bankruptcy
http://www.gurufocus.com/news/987459/teva-bausch-could-be-next-to-file-for-bankruptcy
Nov 19, 2019 - Teva, Bausch Could Be Next to File for Bankruptcy, Stocks: AKAOQ,PTXTQ,TEVA,BHC,ENDP,AMRX,AKRX,AMAG,CLVS, release date:Nov 19, 2019
0
Teva prices upsized $2.1B debt offering
https://seekingalpha.com/news/3520567-teva-prices-upsized-2_1b-debt-offering?source=feed_news_all
Nov 19, 2019 -
0
Why It Is Time To Load Up On Teva Stock
https://seekingalpha.com/article/4305975-time-load-teva-stock?source=feed_tag_israel
Nov 12, 2019 - Investors responded favorably to Teva's third-quarter earnings report.Litigation risks dissipating.Strong pipeline, initial sales of new drugs, and more.
0
Teva Vs. Amneal: JPMorgan Sees Hope For One, Decline For The Other
http://feeds.benzinga.com/~r/benzinga/~3/03Y3GeJlftA/teva-vs-amneal-jpmorgan-sees-hope-for-one-decline-for-the-other
Nov 12, 2019 -
It’s been a rough 2019 for some biotechs. Amneal Pharmaceuticals Inc (NYSE: AMRX) is down 81% year-to-date, while Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is down 41%.
0
Is Teva Pharmaceutical Industries Ltd. (TEVA) a Great Value Stock Right Now?
http://www.zacks.com/stock/news/614175/is-teva-pharmaceutical-industries-ltd-teva-a-great-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-614175
Nov 11, 2019 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
0
Teva launches $1.5B debt offering
https://seekingalpha.com/news/3517269-teva-launches-1_5b-debt-offering?source=feed_news_all
Nov 08, 2019 - Aimed at rolling over three series of outstanding debt due in 2021, Teva Pharmaceutical Industries (TEVA +4.5%) launches a $1.5B private offering Euro-denominated Senior Notes.Pricing and terms have y
0
Teva (TEVA) Q3 Earnings Miss, Stock Up on Guidance Increase
http://www.zacks.com/stock/news/610241/teva-teva-q3-earnings-miss-stock-up-on-guidance-increase?cid=CS-ZC-FT-analyst_blog|earnings_article-610241
Nov 08, 2019 - Teva Pharmaceutical (TEVA) misses earnings estimate but beats the same for sales. The company increases the lower end of its 2019 sales and earnings guidance. Shares rise.
0